Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:("DNA Vaccines 2009 \[2008\]")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

DNA Vaccines 2009 [2008]WEINER, David B.Vaccine. 2010, Vol 28, Num 8, issn 0264-410X, 163 p.Conference Proceedings

Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytesJIANGMEI YIN; ANLAN DAI; ANDING SHEN et al.Vaccine. 2010, Vol 28, Num 8, pp 1924-1931, issn 0264-410X, 8 p.Conference Paper

Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitVALENTIN, Antonio; VON GEGERFELT, Agneta; PAVLAKIS, George N et al.Vaccine. 2010, Vol 28, Num 8, pp 1962-1974, issn 0264-410X, 13 p.Conference Paper

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactiveHUTNICK, Natalie A; CARNATHAN, Diane; DEMERS, Korey et al.Vaccine. 2010, Vol 28, Num 8, pp 1932-1941, issn 0264-410X, 10 p.Conference Paper

Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsKLINMAN, Dennis M; KLASCHIK, Sven; TOMARU, Koji et al.Vaccine. 2010, Vol 28, Num 8, pp 1919-1923, issn 0264-410X, 5 p.Conference Paper

A therapeutic DNA vaccination strategy for autoimmunity and transplantationLI, Alice; JIANFENG CHEN; HATTORI, Masahiro et al.Vaccine. 2010, Vol 28, Num 8, pp 1897-1904, issn 0264-410X, 8 p.Conference Paper

Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentageYING CAI; RODRIGUEZ, Stephen; RAMESWARAN, Ramu et al.Vaccine. 2010, Vol 28, Num 8, pp 2046-2052, issn 0264-410X, 7 p.Conference Paper

Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaquesKRAYNYAK, Kimberly A; KUTZLER, Michele A; CISPER, Neil J et al.Vaccine. 2010, Vol 28, Num 8, pp 1942-1951, issn 0264-410X, 10 p.Conference Paper

An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterizationLEMIALE, Franck; ASEFA, Benyam; YE, Delia et al.Vaccine. 2010, Vol 28, Num 8, pp 1952-1961, issn 0264-410X, 10 p.Conference Paper

Effects of maternal plasmid GHRH treatment on offspring growthKHAN, Amir S; BODLES-BRAKHOP, Angela M; FIOROTTO, Marta L et al.Vaccine. 2010, Vol 28, Num 8, pp 1905-1910, issn 0264-410X, 6 p.Conference Paper

Preparation of pharmaceutical-grade plasmid DNA using methacrylate monolithic columnsSMREKAR, Franc; PODGORNIK, Aleš; CIRINGER, Mateja et al.Vaccine. 2010, Vol 28, Num 8, pp 2039-2045, issn 0264-410X, 7 p.Conference Paper

An immunotherapeutic treatment against flea allergy dermatitis in cats by co-immunization of DNA and protein vaccinesJIN JIN; ZHENG DING; FENGXIA MENG et al.Vaccine. 2010, Vol 28, Num 8, pp 1997-2004, issn 0264-410X, 8 p.Conference Paper

Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccinationSUZUKI, Daisuke; NAGATA, Toshi; EWEDA, Ghada et al.Vaccine. 2010, Vol 28, Num 8, pp 2020-2025, issn 0264-410X, 6 p.Conference Paper

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccinesSHIXIA WANG; MBOUDJEKA, Innocent; GOGUEN, Jon D et al.Vaccine. 2010, Vol 28, Num 8, pp 2011-2019, issn 0264-410X, 9 p.Conference Paper

Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-β/Smad2,3 signalingQIANG ZOU; YIWEI ZHONG; HAIRUI SU et al.Vaccine. 2010, Vol 28, Num 8, pp 2032-2038, issn 0264-410X, 7 p.Conference Paper

The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunizationMASALOVA, Olga V; LESNOVA, Ekaterina I; ISAGULIANTS, Maria G et al.Vaccine. 2010, Vol 28, Num 8, pp 1987-1996, issn 0264-410X, 10 p.Conference Paper

Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigensLIJIN LI; HERNDON, John M; TRUSCOTT, Steven M et al.Vaccine. 2010, Vol 28, Num 8, pp 1911-1918, issn 0264-410X, 8 p.Conference Paper

Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunizationSTARODUBOVA, Elizaveta; BOBERG, Andreas; WAHREN, Britta et al.Vaccine. 2010, Vol 28, Num 8, pp 1975-1986, issn 0264-410X, 12 p.Conference Paper

Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccinationWANG, Li-Xin; NAGATA, Toshi; TSUJIMURA, Kunio et al.Vaccine. 2010, Vol 28, Num 8, pp 2026-2031, issn 0264-410X, 6 p.Conference Paper

Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptidesMUTHUMANI, Karrupiah; LAMBERT, Vance M; KAWALEKAR, Omkar et al.Vaccine. 2010, Vol 28, Num 8, pp 2005-2010, issn 0264-410X, 6 p.Conference Paper

  • Page / 1